CID 16130389

(3-5)hexadecylaminoacetate conjugated oligonucleotide (p-ctccgcttct)

Structural Information

Molecular Formula
C113H161N29O66P10
SMILES
CCCCCCCCCCCCCCCCOC(=O)CNP(=O)(O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OP(=O)(O)OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=NC6=O)N)OP(=O)(O)OCC7C(CC(O7)N8C=CC(=NC8=O)N)OP(=O)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C113H161N29O66P10/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30-179-96(144)41-121-209(159,160)180-47-72-62(32-87(191-72)133-25-20-81(114)122-105(133)150)200-211(163,164)186-52-77-67(37-92(196-77)139-43-58(3)100(146)130-111(139)156)205-216(173,174)184-50-75-64(34-89(194-75)135-27-22-83(116)124-107(135)152)202-212(165,166)182-49-74-66(36-91(193-74)137-29-24-85(118)126-109(137)154)204-214(169,170)189-55-80-70(40-95(199-80)142-56-120-97-98(142)127-104(119)128-103(97)149)208-218(177,178)185-51-76-65(35-90(195-76)136-28-23-84(117)125-108(136)153)203-213(167,168)187-53-78-69(39-94(197-78)141-45-60(5)102(148)132-113(141)158)207-217(175,176)188-54-79-68(38-93(198-79)140-44-59(4)101(147)131-112(140)157)206-215(171,172)183-48-73-63(33-88(192-73)134-26-21-82(115)123-106(134)151)201-210(161,162)181-46-71-61(143)31-86(190-71)138-42-57(2)99(145)129-110(138)155/h20-29,42-45,56,61-80,86-95,143H,6-19,30-41,46-55H2,1-5H3,(H,161,162)(H,163,164)(H,165,166)(H,167,168)(H,169,170)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H2,114,122,150)(H2,115,123,151)(H2,116,124,152)(H2,117,125,153)(H2,118,126,154)(H2,121,159,160)(H,129,145,155)(H,130,146,156)(H,131,147,157)(H,132,148,158)(H3,119,127,128,149)
InChIKey
ISTCWMMBKCWRTP-UHFFFAOYSA-N
Compound name
[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-N-(2-hexadecoxy-2-oxoethyl)phosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3289.751 Da
Monoisotopic Mass

-13.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3290.7583 295.1
[M+Na]+ 3312.7402 300.9
[M-H]- 3288.7437 299.1
[M+NH4]+ 3307.7848 297.4
[M+K]+ 3328.7142 296.9
[M+H-H2O]+ 3272.7483 293.3
[M+HCOO]- 3334.7492 297.4
[M+CH3COO]- 3348.7649 297.8
[M+Na-2H]- 3310.7257 307.7
[M]+ 3289.7505 294.4
[M]- 3289.7515 294.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.